• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二次诊断咨询项目的成效:成本效益视角

The efficacy of second-opinion consultation programs: a cost-benefit perspective.

作者信息

Ruchlin H S, Finkel M L, McCarthy E G

出版信息

Med Care. 1982 Jan;20(1):3-20. doi: 10.1097/00005650-198201000-00002.

DOI:10.1097/00005650-198201000-00002
PMID:6804722
Abstract

This study evaluates a mandatory second-opinion consultation program administered on behalf of a large Taft-Hartley welfare fund providing medical care coverage for 120,000 beneficiaries and covered dependents. During a two-year intake period (1977-1978), 2,284 individuals received second-opinion consultations for an elective surgical procedure recommended by a first-contact physician or surgeon. Of this group, 366 received a nonconfirmation of their need for surgery. Medical claims data were available for 342 individuals in this group, and they constitute the base for the current analysis. A comparable number of individuals who received a positive confirmation were randomly selected and served as a control for estimating program savings. Both groups were followed for a one-year period from the date of their consultations. Total program savings were estimated at $534,791. Of this amount, medical care utilization savings were $361,756 and productivity savings were $173,035. The cost of the program was $203,300, yielding a benefit-cost ratio of 2.63. These findings indicate that mandatory second-opinion consultation programs, which are consumer oriented and intervene before care is rendered, are clearly cost-effective.

摘要

本研究评估了一项代表大型塔夫脱-哈特利福利基金实施的强制二次会诊计划,该福利基金为12万名受益人和受抚养人提供医疗保健覆盖。在为期两年的接收期(1977年至1978年)内,2284人就首诊医生或外科医生推荐的择期手术接受了二次会诊。在这一组中,366人被告知其不需要手术。该组中有342人的医疗理赔数据可用,这些数据构成了当前分析的基础。随机选择了数量相当的得到肯定确认的个体作为对照组,用于估计该计划节省的费用。两组均从会诊之日起随访一年。该计划总共节省了534791美元。其中,医疗保健利用节省了361756美元,生产力节省了173035美元。该计划的成本为203300美元,效益成本比为2.63。这些发现表明,以消费者为导向且在提供医疗服务之前进行干预的强制二次会诊计划显然具有成本效益。

相似文献

1
The efficacy of second-opinion consultation programs: a cost-benefit perspective.二次诊断咨询项目的成效:成本效益视角
Med Care. 1982 Jan;20(1):3-20. doi: 10.1097/00005650-198201000-00002.
2
Second surgical opinion programs: dead or alive?二次手术意见项目:是死是活?
J Am Coll Surg. 1997 Nov;185(5):451-6.
3
Procedure-specific costs and savings in a mandatory program for second opinion on surgery.手术二次诊断强制项目中的特定手术成本与节约情况。
QRB Qual Rev Bull. 1990 Jan;16(1):25-32. doi: 10.1016/s0097-5990(16)30331-1.
4
Impact of a mandatory second-opinion program on medicaid surgery rates.强制二次诊断程序对医疗补助手术率的影响。
Med Care. 1982 Jan;20(1):21-45. doi: 10.1097/00005650-198201000-00003.
5
Second opinion elective surgery programs: outcome status over time.二次意见择期手术项目:随时间推移的结果状况
Med Care. 1978 Dec;16(12):984-94. doi: 10.1097/00005650-197812000-00002.
6
Second opinion programs: continued savings from nonconfirmed surgeries.二次诊断项目:非确诊手术持续节省费用。
Empl Benefits J. 1992 Sep;17(3):35-40.
7
Second opinion plans seen saving money.二次诊断方案有望节省资金。
Natl Underwrit Life Health. 1981 Feb 21;85(8):1, 20-1.
8
Second opinions on elective surgery. The Cornell/New York Hospital study.择期手术的二次诊断意见。康奈尔大学/纽约医院研究。
Lancet. 1981 Jun 20;1(8234):1352-4. doi: 10.1016/s0140-6736(81)92527-7.
9
An analysis of nonconfirmation rates. Experiences of a surgical second opinion program.非确认率分析。外科二次诊断项目的经验。
JAMA. 1979 Nov 30;242(22):2424-7.
10
Evaluation of a surgical second opinion program.
QRB Qual Rev Bull. 1983 Jan;9(1):11-9.

引用本文的文献

1
How prior spectacle prescriptions shape diagnostic behavior: evidence from a randomized field experiment on vision care in Western China.既往眼镜处方如何塑造诊断行为:来自中国西部视力保健随机现场试验的证据。
BMC Health Serv Res. 2025 Aug 13;25(1):1074. doi: 10.1186/s12913-025-13265-9.
2
[Less surgery and lower cost due to back pain in a care program with an interdisciplinary second opinion procedure : A controlled non-randomized intervention study based on claims data].[在一项包含跨学科二次诊断程序的护理方案中,背痛导致手术减少及成本降低:一项基于索赔数据的对照非随机干预研究]
Schmerz. 2023 Apr;37(2):123-133. doi: 10.1007/s00482-022-00624-2. Epub 2022 Feb 22.
3
Second opinion utilization by healthcare insurance type in a mixed private-public healthcare system: a population-based study.
混合公私医疗体系中医疗保险类型的二次诊疗意见使用情况:一项基于人群的研究
BMJ Open. 2019 Jul 27;9(7):e025673. doi: 10.1136/bmjopen-2018-025673.
4
The Value of a Second Opinion for Breast Cancer Patients Referred to a National Cancer Institute (NCI)-Designated Cancer Center with a Multidisciplinary Breast Tumor Board.对于转介至拥有多学科乳腺肿瘤委员会的美国国家癌症研究所 (NCI) 指定癌症中心的乳腺癌患者,第二诊疗意见的价值。
Ann Surg Oncol. 2018 Oct;25(10):2953-2957. doi: 10.1245/s10434-018-6599-y. Epub 2018 Jul 3.
5
The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group.软组织和内脏肉瘤、GIST 和硬纤维瘤的集中组织学检查的节省效果:法国肉瘤组病理学家的经验。
PLoS One. 2018 Apr 5;13(4):e0193330. doi: 10.1371/journal.pone.0193330. eCollection 2018.
6
Seeking a second medical opinion: composition, reasons and perceived outcomes in Israel.寻求第二种医学意见:以色列的构成、原因及感知结果
Isr J Health Policy Res. 2017 Dec 8;6(1):67. doi: 10.1186/s13584-017-0191-y.
7
Managed care: Practice, pitfalls, and potential.管理式医疗:实践、陷阱与潜力。
Health Care Financ Rev. 1992 Mar;1991(Suppl):27-34.
8
Histopathologic review of previously negative prostatic core needle biopsies following a new diagnosis of adenocarcinoma of the prostate by core needle biopsies: implications for quality assurance programs.经芯针活检新诊断为前列腺腺癌后,对先前阴性的前列腺芯针活检标本进行组织病理学复查:对质量保证计划的启示
Clin Med Pathol. 2008;1:77-81. doi: 10.4137/cpath.s581. Epub 2008 Sep 16.
9
What doctors think about the impact of managed care tools on quality of care, costs, autonomy, and relations with patients.医生如何看待管理式医疗工具对医疗质量、成本、自主性以及与患者关系的影响。
BMC Health Serv Res. 2010 Dec 7;10:331. doi: 10.1186/1472-6963-10-331.
10
The reliability of cost-utility estimates in cost-per-QALY league tables .成本效益分析联盟表中成本效用估计的可靠性。
Pharmacoeconomics. 1993 May;3(5):345-53. doi: 10.2165/00019053-199303050-00002.